Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics

The Kappa Statistic in Reliability Studies: Use, Interpretation, and Sample Size Requirements

Julius Sim, Chris Wright · Physical Therapy · 2005 · 4.1K citations · Full text

Health Professions, Biostatistics, Musculoskeletal Medicine +15

WINPEPI updated: computer programs for epidemiologists, and their teaching potential

J. H. Abramson · Epidemiologic Perspectives & Innovations · 2011 · 849 citations · Full text

Public Health, Biostatistics, Health Informatics +13

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

Felix W. Frueh, Shashi Amur, Padmaja Mummaneni et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2008 · 306 citations

Medicine, Pharmacology, Pharmacy Practice +15

The frequency of inappropriate tablet splitting in primary care

Renate Quinzler, Christiane Gasse, Antonius Schneider et al. · European Journal of Clinical Pharmacology · 2006 · 127 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +6

Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?

Sharon J. Gardiner, Evan J. Begg · Pharmacogenetics and Genomics · 2005 · 90 citations

Medicine, Pharmacology, Clinical Pharmacology +13